Detail akcie ICU Medical Inc online

Business Summary: ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
Financial Summary: BRIEF: For the six months ended 30 June 2025, ICU Medical Inc revenues decreased 1% to $1.15B. Net income totaled $19.9M vs. loss of $60.9M. Revenues reflect Infusion Consumables segment decrease of 46% to $273.1M, Vital Care segment decrease of 44% to $280.2M, United States segment decrease of 3% to $723.7M. Net Income reflects Interest Expense - Balancing value decrease of 9% to $48.2M (expense).